du-21220 has been researched along with Hyaline Membrane Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blot, P; Milliez, J; Sureau, C | 1 |
| Egan, EA; Kwong, MS | 1 |
2 other study(ies) available for du-21220 and Hyaline Membrane Disease
| Article | Year |
|---|---|
A case report of maternal death associated with betamimetics and betamethasone administration in premature labor.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Betamethasone; Female; Heart Failure; Humans; Hyaline Membrane Disease; Infant, Newborn; Maternal-Fetal Exchange; Obstetric Labor, Premature; Pregnancy; Ritodrine | 1980 |
Reduced incidence of hyaline membrane disease in extremely premature infants following delay of delivery in mother with preterm labor: use of ritodrine and betamethasone.
Topics: Betamethasone; Female; Humans; Hyaline Membrane Disease; Infant, Newborn; Intermittent Positive-Pressure Ventilation; Obstetric Labor, Premature; Oxygen Consumption; Pregnancy; Respiratory Distress Syndrome, Newborn; Ritodrine; Sex Factors; Time Factors; Twins | 1986 |